Moxalactam in the treatment of typhoid fever

M. Uwaydah; S. Vartivarian; S. Shatila; I. Raad; H. Harakeh; N. T. Nassar

doi:10.1128/AAC.30.2.338

Moxalactam in the treatment of typhoid fever

M. Uwaydah, S. Vartivarian, S. Shatila, I. Raad, H. Harakeh, N. T. Nassar

Infectious Diseases, Infection Control, and Employee Health

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Moxalactam therapy was evaluated in 25 patients with typhoid fever. A satisfactory initial response was observed in all cases. Treatment for 3 days resulted in a much higher relapse rate (three of five patients) than did treatment for 5 days (one of nine patients). None of the 11 patients treated for 10 to 11 days relapsed. Moxalactam is effective in typhoid fever, but its use is better restricted to special indications.

Original language	English (US)
Pages (from-to)	338-339
Number of pages	2
Journal	Antimicrobial agents and chemotherapy
Volume	30
Issue number	2
DOIs	https://doi.org/10.1128/AAC.30.2.338
State	Published - 1986

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.30.2.338

Cite this

@article{538f8901c36d475e93a0074130542f3f,

title = "Moxalactam in the treatment of typhoid fever",

abstract = "Moxalactam therapy was evaluated in 25 patients with typhoid fever. A satisfactory initial response was observed in all cases. Treatment for 3 days resulted in a much higher relapse rate (three of five patients) than did treatment for 5 days (one of nine patients). None of the 11 patients treated for 10 to 11 days relapsed. Moxalactam is effective in typhoid fever, but its use is better restricted to special indications.",

author = "M. Uwaydah and S. Vartivarian and S. Shatila and I. Raad and H. Harakeh and Nassar, {N. T.}",

year = "1986",

doi = "10.1128/AAC.30.2.338",

language = "English (US)",

volume = "30",

pages = "338--339",

journal = "Antimicrobial agents and chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - Moxalactam in the treatment of typhoid fever

AU - Uwaydah, M.

AU - Vartivarian, S.

AU - Shatila, S.

AU - Raad, I.

AU - Harakeh, H.

AU - Nassar, N. T.

PY - 1986

Y1 - 1986

N2 - Moxalactam therapy was evaluated in 25 patients with typhoid fever. A satisfactory initial response was observed in all cases. Treatment for 3 days resulted in a much higher relapse rate (three of five patients) than did treatment for 5 days (one of nine patients). None of the 11 patients treated for 10 to 11 days relapsed. Moxalactam is effective in typhoid fever, but its use is better restricted to special indications.

AB - Moxalactam therapy was evaluated in 25 patients with typhoid fever. A satisfactory initial response was observed in all cases. Treatment for 3 days resulted in a much higher relapse rate (three of five patients) than did treatment for 5 days (one of nine patients). None of the 11 patients treated for 10 to 11 days relapsed. Moxalactam is effective in typhoid fever, but its use is better restricted to special indications.

UR - http://www.scopus.com/inward/record.url?scp=0022529104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022529104&partnerID=8YFLogxK

U2 - 10.1128/AAC.30.2.338

DO - 10.1128/AAC.30.2.338

M3 - Article

C2 - 3532946

AN - SCOPUS:0022529104

SN - 0066-4804

VL - 30

SP - 338

EP - 339

JO - Antimicrobial agents and chemotherapy

JF - Antimicrobial agents and chemotherapy

IS - 2

ER -

Moxalactam in the treatment of typhoid fever

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this